Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease

Journal of Neuroinflammation

Volumn 5, Issue , 2008, Pages

  Gnjec, Anastazija ^a,b   D'Costa, Katarzyna J ^a,b   Laws, Simon M ^a,b   Hedley, Ross ^a,b   Balakrishnan, Kelvin ^a,b   Taddei, Kevin ^a,b   Martins, Georgia ^a,b   Paton, Athena ^a,b   Verdile, Giuseppe ^a,b   Gandy, Samuel E ^c   Anthony, G Anthony ^d   Brooks, William S ^e   Bennett, Hayley ^d   Piguet, Olivier ^d   Price, Patricia ^b,e,f   Miklossy, Judith ^g   Hallmayer, Joachim ^h   McGeer, Patrick L ^g   Martins, Ralph N ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CYTOKINE; HLA B ASSOCIATED TRANSCRIPT 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BAT1 PROTEIN, HUMAN; DEAD BOX PROTEIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; BRAIN TISSUE; COHORT ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AUSTRALIA; BRAIN; DEAD-BOX RNA HELICASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 52449106159     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-5-36     Document Type: Article

References (43)

1. McGeer EG McGeer PL The importance of inflammatory mechanisms in Alzheimer disease Exp Gerontol 1998, 33:371-378. 10.1016/ S0531-5565(98)00013-8 9762518
2. Gonzalez-Scarano F Baltuch G Microglia as mediators of inflammatory and degenerative diseases Annu Rev Neurosci 1999, 22:219-240. 10.1146/ annurev.neuro.22.1.219 10202538
3. McGeer PL McGeer EG Polymorphisms in inflammatory genes and the risk of Alzheimer disease Arch Neurol 2001, 58:1790-1792. 10.1001/ archneur.58.11.1790 11708985
4. Grimaldi LM Casadei VM Ferri C Veglia F Licastro F Annoni G Biunno I De Bellis G Sorbi S Mariani C Canal N Griffin WS Franceschi M Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism Ann Neurol 2000, 47:361-365. 10.1002/ 1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N 10716256
5. Faltraco F Burger K Zill P Teipel SJ Moller HJ Hampel H Bondy B Ackenheil M Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk J Am Geriatr Soc 2003, 51:578-579. 10.1046/j.1532-5415.2003.51177.x 12657090
6. Alvarez V Mata IF Gonzalez P Lahoz CH Martinez C Pena J Guisasola LM Coto E Association between the TNFalpha-308 A/G polymorphism and the onset-age of Alzheimer disease Am J Med Genet 2002, 114:574-577. 10.1002/ ajmg.10515 12116197
7. Culpan D MacGowan SH Ford JM Nicoll JA Griffin WS Dewar D Cairns NJ Hughes A Kehoe PG Wilcock GK Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease Neurosci Lett 2003, 350:61-65. 10.1016/S0304-3940(03)00854-1 12962917
8. Hedley R Hallmayer J Groth DM Brooks WS Gandy SE Martins RN Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia Ann Neurol 2002, 51:795-797. 10.1002/ana.10196 12112093
9. Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Roses AD Haines JL Pericak-Vance MA Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993, 261:921-923. 10.1126/science.8346443 8346443
10. Craft S Teri L Edland SD Kukull WA Schellenberg G McCormick WC Bowen JD Larson EB Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease Neurology 1998, 51:149-153. 9674794
11. McCusker SM Curran MD Dynan KB McCullagh CD Urquhart DD Middleton D Patterson CC McIlroy SP Passmore AP Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: A case-control study Lancet 2001, 357:436-43.9 10.1016/S0140-6736(00)04008-3 11273064
12. Infante J Llorca J Berciano J Combarros O No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease Neurosci Lett 2002, 328:71-73. 10.1016/S0304-3940(02)00453-6 12123862
13. Martins RN Clarnette R Fisher C Broe GA Brooks WS Montgomery P Gandy SE ApoE genotypes in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome Neuroreport 1995, 6:1513-1516. 7579137
14. Laws SM Taddei K Fisher C Small D Clarnette R Hallmayer J Brooks WS Kwok JBJ Schofield PR Gandy SE Martins RN Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer's Disease Alzheimer's Reports 1999, 2:219-223.
15. Wilson AG di Giovine FS Duff GW Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases J Inflamm 1995, 45:1-12. 7583349
16. Wilson AG de Vries N Pociot F di Giovine FS Putte van der LB Duff GW An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles J Exp Med 1993, 177:557-560. 2190902 8426126 10.1084/jem.177.2.557
17. Wilson AG Symons JA McDowell TL McDevitt HO Duff GW Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proc Natl Acad Sci USA 1997, 94:3195-3199. 20345 9096369 10.1073/pnas.94.7.3195
18. Collins JS Perry RT Watson B Jr Harrell LE Acton RT Blacker D Albert MS Tanzi RE Bassett SS McInnis MG Campbell RD Go RC Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer Disease Genetics Initiative Am J Med Genet 2000, 96:823-830. 10.1002/ 1096-8628(20001204)96:6<823::AID-AJMG26<3.0.CO;2-I 11121190
19. Perry RT Collins JS Harrell LE Acton RT Go RC Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls Am J Med Genet 2001, 105:332-342. 10.1002/ajmg.1371 11378846
20. Allcock RJ Williams JH Price P The central MHC gene, BAT1, may encode a protein that down-regulates cytokine production Genes Cells 2001, 6:487-494. 10.1046/j.1365-2443.2001.00435.x 11380625
21. Wong AM Allcock RJ Cheong KY Christiansen FT Price P Alleles of the proximal promoter of BAT1, a putative anti-inflammatory gene adjacent to the TNF cluster, reduce transcription on a disease-associated MHC haplotype Genes Cells 2003, 8:403-412. 10.1046/j.1365-2443.2002.00641.x 12653967
22. Spies T Bresnahan M Strominger JL Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B Proc Natl Acad Sci USA 1989, 86:8955-8958. 298409 2813433 10.1073/ pnas.86.22.8955
23. de la Cruz J Kressler D Linder P Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families Trends Biochem Sci 1999, 24:192-198. 10.1016/S0968-0004(99)01376-6 10322435
24. Pause A Sonenberg N Mutational analysis of a DEAD box RNA helicase: The mammalian translation initiation factor eIF-4A Embo J 1992, 11:2643-2654. 556740 1378397
25. Allcock RJ Windsor L Gut IG Kucharzak R Sobre L Lechner D Garnier JG Baltic S Christiansen FT Price P High-Density SNP genotyping defines 17 distinct haplotypes of the TNF block in the Caucasian population: implications for haplotype tagging Hum Mutat 2004, 24:517-525. 10.1002/ humu.20100 15523649
26. Waite LM Broe GA Creasey H Grayson D Edelbrock D O'Toole B Neurological signs, aging, and the neurodegenerative syndromes Arch Neurol 1996, 53:498-502. 8660150
27. Waite LM Broe GA Creasey H Grayson DA Cullen JS O'Toole B Edelbrock D Dobson M Neurodegenerative and other chronic disorders among people aged 75 years and over in the community Med J Aust 1997, 167:429-432. 9364162
28. Hixson JE Borenstein S Cox LA Rainwater DL VandeBerg JL The baboon gene for apolipoprotein A-I: Characterization of a cDNA clone and identification of DNA polymorphisms for genetic studies of cholesterol metabolism Gene 1988, 74:483-490. 10.1016/0378-1119(88)90181-3 2907746
29. Kato T Honda M Kuwata S Juji T Kunugi H Nanko S Fukuda M Honda Y Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy Am J Med Genet 1999, 88:301-304. 10.1002/(SICI)1096-8628(19990820)88:4<301::AID-AJMG4>3.0.CO;2-3 10402494
30. Allcock RJ Baluchova K Cheong KY Price P Haplotypic single nucleotide polymorphisms in the central MHC gene IKBL, a potential regulator of NF-kappaB function Immunogenetics 2001, 52(3-4):289-293. 11220632
31. Tregouet DA Escolano S Tiret L Mallet A Golmard JL A new algorithm for haplotype-based association analysis: The Stochastic-EM algorithm Ann Hum Genet 2004, 68:165-177. 10.1046/j.1529-8817.2003.00085.x 15008795
32. Schaid DJ Jacobsen SJ Biased tests of association: Comparisons of allele frequencies when departing from Hardy-Weinberg proportions Am J Epidemiol 1999, 149:706-711. 10206619
33. Gupta A Pansari K Inflammation and Alzheimer's disease Int J Clin Pract 2003, 57:36-39. 12587940
34. De Luigi A Pizzimenti S Quadri P Lucca U Tettamanti M Fragiacomo C De Simoni MG Peripheral inflammatory response in Alzheimer's disease and multiinfarct dementia Neurobiol Dis 2002, 11:308-314. 10.1006/ nbdi.2002.0556 12505423
35. Sala G Galimberti G Canevari C Raggi ME Isella V Facheris M Appollonio I Ferrarese C Peripheral cytokine release in Alzheimer patients: correlation with disease severity Neurobiol Aging 2003, 24:909-914. 10.1016/S0197-4580(03)00010-1 12928049
36. Lucarelli P Piciullo A Verdecchia M Palmarino M Arpino C Curatolo P The role of -850 tumor necrosis factor-alpha and apolipoprotein E genetic polymorphism in patients with Down's syndrome-related dementia Neurosci Lett 2003, 352:29-32. 10.1016/j.neulet.2003.08.021 14615042
37. Jensen TH Boulay J Rosbash M Libri D The DECD box putative ATPase Sub2p is an early mRNA export factor Curr Biol 2001, 11:1711-1715. 10.1016/ S0960-9822(01)00529-2 11696331
38. Strasser K Hurt E Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p Nature 2001, 413:648-652. 10.1038/35098113 11675790
39. Gatfield D Le Hir H Schmitt C Braun IC Kocher T Wilm M Izaurralde E The DExH/D protein HEL/UAP56 is essential for mRNA nuclear export in Drosophila Curr Biol 2001, 11:1716-1721. 10.1016/S0960-9822(01)00532-2 11696332
40. Luo ML Zhou Z Magni K Christoforides C Rappsilber J Mann M Reed R Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly Nature 2001, 413:644-647. 10.1038/35098106 11675789
41. Price P Wong AM Williamson D Voon D Baltic S Allcock RJ Boodhoo A Christiansen FT Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors Hum Mol Genet 2004, 13:967-974. 10.1093/hmg/ddh113 15028669
42. van Heel DA Udalova IA De Silva AP McGovern DP Kinouchi Y Hull J Lench NJ Cardon LR Carey AH Jewell DP Kwiatkowski D Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors Hum Mol Genet 2002, 11:1281-1289. 10.1093/hmg/11.11.1281 12019209
43. Allcock RJ Price P Gaudieri S Leelayuwat C Witt CS Dawkins RL Characterisation of the human central MHC gene, BAT1: Genomic structure and expression Exp Clin Immunogenet 1999, 16:98-106. 10.1159/000019100 10343160